STUP-001
- Generic Name
- STUP-001
First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury
Phase 1
Not yet recruiting
- Conditions
- Spinal Cord InjuryChronic Spinal Cord Injury
- Interventions
- First Posted Date
- 2025-04-11
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 9
- Registration Number
- NCT06922890
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath